Skip to main content

Table 3 Descriptives of Anticholinergic Medication Use Prevalence at Baseline and Year 3

From: Anticholinergic medication use and falls in postmenopausal women: findings from the women’s health initiative cohort study

 

Baseline

Year 3

 

N

%

N

%

Any Use

6940

100.00

6985

100.00

Number of Agents

    

 1

6332

91.24

6333

90.67

 2+

608

8.76

652

9.33

Duration

    

  <1 year

1775

25.58

1786

25.57

 1–3 years

2514

36.22

3306

47.33

  >3 years

2651

38.20

1893

27.10

Specific Anticholinergic Class

    

 Antihistamines

3136

45.19

2355

33.72

 Antidepressants/Antipsychotics

2252

32.45

2381

34.09

 Gastrointestinal antispasmodics

670

9.65

499

7.14

 Urinary antimuscarinics

582

8.39

1653

23.66

 Antivertigo/antiemetics

521

7.51

429

6.14

 Miscellaneousa

344

4.96

301

4.31

  1. aMiscellaneous: antiparkinson agents and disopyramide